Pluri Inc., a bio-technology company, creates cell-based products for commercial use. The company's technology platform, a 3D cell expansion system, advances novel cell-based solutions for a range of initiatives from medicine and climate change to food scarcity, animal cruelty, and other. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.